Answer
Yes. A ready-to-use subcutaneous formulation is licensed for adults in suitable indications; intravenous infusion remains another formulation.
Sources for this answer
- OPDIVO 10 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- OPDIVO 600 mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.